Synergy CHC Corp. (SNYR) IPO - S-1 Filing, Stock & Insider Activity
Synergy CHC Corp. IPO - Status & S-1 Filing
- Ticker: SNYR
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-05-15
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 101,710,000
- SEC CIK: 0001562733 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Synergy CHC Corp. (SNYR) has filed 3 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-01. 5 Form 8-K material event filings were reported by SNYR in the last 90 days. InsiderAlpha tracks every SNYR SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Synergy CHC Corp. (SNYR)
Synergy CHC Corp. trades under the ticker SNYR. InsiderAlpha tracks 10 primary SEC Form 4 filings from 5 reporting insiders for SNYR since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Medicinal Chemicals & Botanical Products (SIC 2833) |
| SEC CIK | 0001562733 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 3 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Latest Form 4 filing | 2026-07-01 |
Recent SNYR Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Nitin Kaushal | Director | A - Grant or award | 306.4K | $0.00 | - | SEC | |
| Teresa Brigid Thompson | Director | A - Grant or award | 25.8K | $0.00 | - | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 100 | $3.69 | $369 | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 250 | $3.66 | $915 | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 350 | $3.90 | $1K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 300 | $3.83 | $1K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 300 | $3.54 | $1K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 750 | $3.20 | $2K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 1.4K | $3.19 | $4K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 400 | $3.15 | $1K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 800 | $3.36 | $3K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 700 | $3.26 | $2K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 1.8K | $3.22 | $6K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 3.8K | $3.23 | $12K | SEC | |
| Jack Ross | CEO and Chairman | P - Open-market purchase | 250 | $3.05 | $762 | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Synergy CHC Corp. (SNYR). Updated in real time as new filings are submitted to the SEC.
Most-Active SNYR Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Jack Ross | 2 | - |
| Alfred Baumeler | 2 | - |
| Jaime Fickett | 2 | - |
Recent SNYR Form 8-K Material Events
- - Item 8.01 [SEC]
- - Item 5.02, 5.07, 9.01 [SEC]
- - Item 3.01 [SEC]
- - Item 2.02, 9.01 [SEC]
- - Item 1.01, 9.01 [SEC]
Recent Insider Filings
- - Alfred Baumeler (President)
- - Jaime Fickett (Chief Financial Officer)
- - Jack Ross (CEO and Chairman)
- - Nitin Kaushal (Director)
- - Teresa Brigid Thompson (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SNYR insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
SNYR Insider Trading - FAQ
- What is the latest insider trade for SNYR?
- Synergy CHC Corp. (SNYR) had 3 insider filings in the last 90 days, with the most recent on 2026-07-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying SNYR stock?
- 0 insider purchases of SNYR were filed in the last 90 days.
- How many insiders are selling SNYR stock?
- 0 insider sales of SNYR were filed in the last 90 days.
- Where can I see SNYR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks SNYR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $SRRK Scholar Rock Holding Corp
- $SSII SS Innovations International, Inc.
- $STAA STAAR SURGICAL CO
- $STTK Shattuck Labs, Inc.
- $TCRX TScan Therapeutics, Inc.
- $TECX Tectonic Therapeutic, Inc.
- $TNON Tenon Medical, Inc.
- $TYRA Tyra Biosciences, Inc.
- $UNH UNITEDHEALTH GROUP INC
- $UTHR UNITED THERAPEUTICS Corp
Related Companies - Recent Insider Activity
- USANA HEALTH SCIENCES INC (USNA)
- MARIMED INC. (MRMD)
- Definium Therapeutics, Inc. (DFTX)
- Canopy Growth Corp (CGC)
- Niagen Bioscience, Inc. (NAGE)
- Tilray Brands, Inc. (TLRY)
- Cronos Group Inc. (CRON)
- MANNATECH INC (MTEX)
- Trulieve Cannabis Corp. (TRLV)
- FITLIFE BRANDS, INC. (FTLF)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live SNYR dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.